[ Back ]

Verve Therapeutics

www.vervetx.com
201 Brookline Avenue, Suite 601
Boston, MA 02215

Company Info

Phone
(617) 603-0070

Year Established
2018

Ticker
VERV

Exchange
NASDAQ

Contacts

Morgan Jones
Senior Director, Business Development

Company Description

Verve is pioneering single-course gene editing medicines to treat cardiovascular disease

bioinnovatise accelerates scientific discovery by providing fast, reliable, and high-quality CDMO services for plasmid DNA and viral vector-based research.